UBS Group AG - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$11,000
-86.1%
5,188
-80.4%
0.00%
Q2 2021$79,000
+75.6%
26,449
+63.2%
0.00%
Q1 2021$45,000
-2.2%
16,206
-16.0%
0.00%
Q4 2020$46,000
+360.0%
19,300
+309.8%
0.00%
Q3 2020$10,000
-84.1%
4,710
-71.4%
0.00%
Q2 2020$63,000
+34.0%
16,488
-34.2%
0.00%
Q1 2020$47,000
-53.9%
25,041
-48.9%
0.00%
Q4 2019$102,000
+72.9%
49,027
+99.8%
0.00%
Q3 2019$59,000
+391.7%
24,541
+563.3%
0.00%
Q2 2019$12,000
-42.9%
3,700
-12.0%
0.00%
Q1 2019$21,000
+90.9%
4,203
+79.2%
0.00%
Q4 2018$11,000
+450.0%
2,345
+422.3%
0.00%
Q3 2018$2,0000.0%449
+70.1%
0.00%
Q4 2017$2,000
-90.0%
264
-90.7%
0.00%
Q3 2017$20,000
+400.0%
2,840
+278.2%
0.00%
Q3 2016$4,000
-50.0%
751
-63.8%
0.00%
Q2 2016$8,000
-42.9%
2,077
-30.0%
0.00%
Q1 2016$14,000
-36.4%
2,969
+1.6%
0.00%
Q4 2015$22,0002,9230.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON CORP 5,376,039$47,309,00051.34%
Lyon Street Capital, LLC 3,182,149$28,162,0009.07%
Opaleye Management Inc. 1,590,000$14,071,0004.02%
Broadfin Capital, LLC 2,793,752$24,725,0003.85%
Vivo Capital, LLC 1,918,132$16,975,0002.40%
ARMISTICE CAPITAL, LLC 3,372,000$29,842,0002.28%
PRECEPT MANAGEMENT LLC 470,000$4,160,0001.73%
NEA Management Company, LLC 4,141,308$36,651,0001.63%
Harvest Capital Strategies LLC 825,000$7,301,0001.14%
Granite Point Capital Management, L.P. 567,895$5,026,0000.49%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders